Description
SX-SL 20 mg Dual-Action Blend (10 mg + 10 mg)
This advanced 20 mg combination blend couples two highly sought-after reference compounds—optimized at an exact 1:1 ratio of 10 mg each—into a single, uniform laboratory solution. Synthesized to meet stringent analytical benchmarks, this matrix is designed for precise comparative testing and synchronized evaluation in research models.
Technical Specifications
-
Composition: 10 mg Compound A + 10 mg Compound B
-
Total Mass: 20 mg active material per unit
-
Purity Profile: Greater than 99% (verified via HPLC analysis)
-
Form: Dry lyophilized powder in an airtight glass vial
-
Storage Requirements: Store at -20°C for long-term stability; protect from direct light and moisture.
Core Research Objectives
-
Neurological Integration: Investigating how these two distinct biochemical structures interact when introduced simultaneously to cellular models.
-
Synergistic Pathways: Evaluating potential compounding effects on metabolic stability, degradation rates, and receptor affinity.
-
Comparative Kinetics: Mapping molecular behavior and structural integrity during localized laboratory testing.
⚠️ STRICT REGULATORY & SAFETY NOTICE
For Laboratory Research Use Only. This product is synthesized exclusively for in vitro diagnostic testing, chemical analysis, and laboratory experiments. It is explicitly not for human or animal consumption, therapeutic application, or medical use. May only be handled by qualified laboratory personnel.
